Feasibility study for an evaluation system of effect and side effect chemotherapy for oral cancer utilizing time PCR
Feasibility study for an evaluation system of effect and side effect chemotherapy for oral cancer utilizing time PCR
批准号:
13672077
负责人:
MORIKAWA Hidehiro
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
本课题的目的是利用真实的时间PCR技术建立一个较为准确的口腔癌化疗疗效和副作用的评价体系。为此,我们试图检测口腔鳞状细胞癌患者化疗过程中细针穿刺获得的外周血细胞和肿瘤细胞中凋亡相关蛋白的mRNA表达。然而.由于尚未建立此类检查,因此开始了使用经或未经抗癌剂处理的培养细胞的可行性研究。经顺铂和/或5-FU治疗后,部分患者外周血细胞凋亡诱导蛋白Fas、Bax、Caspase-2、3、8、9的mRNA表达增加。另一方面,经顺铂和(或)5-FU处理后,部分病例的外周血细胞中Bcl-2、Bcl-X_1、c-IAP 2、XIAP等凋亡抑制蛋白的mRNA表达增加。这些结果表明,外周血细胞可能是敏感的抗癌药物在化疗过程中,和抗癌药物的副作用,可以评估通过检查的凋亡相关蛋白的mRNA表达。目前,我们尝试将口腔癌患者的外周血细胞用于口腔癌化疗的临床研究。在本研究中,我们将研究糖尿病相关蛋白的mRNA表达水平与副作用的临床表现之间的关系。由于通过使用外周血细胞的可行性研究建立的技术诀窍适用于使用细针穿刺获得的肿瘤细胞的检查,因此本项目中提出的评估系统将产生有关抗癌剂效果的有用信息。
英文摘要
The aim of this project is establishment of a mere accurate evaluation system of effect and side effect of chemotherapy for oral cancer utilizing real time PCR. For this purpose, we attempted to examine the mRNA expression of apoptosisrelated proteins in peripheral blood cells and tumor cells of patients with oral squamous cell carcinoma obtained by fine needle aspiration during the course of anticancer chemotherapy. However. Since this kind of examination has not been established so started on a feasibility study using culture cells treated with or without anticancer agents. After the treatment wife cisplatin and/or 5-FU, mRNA expression of apoptosis-mediating proteins inducing Fas,Bax, Caspase-2,3,8,9 in the cultured peripheral blood cells was increased in some cases. On the other hand, in the cultured peripheral blood cells after the treatment with cisplatin and/or 5-FU, some cases also showed increased expression of mRNA of apoptosis-suppressing proteins incliding Bcl-2, Bcl-X_1, c-IAP2, XIAP. These findings suggest that peripheral blood cells may be susceptible to anticancer agents during the course of chemotherapy, and the side effect of the anticancer agents can be evaluated be evaluated by examination of mRNA expression of apoptosis-related proteins. At preaent, we anttempt to start on the clinical study using peripheral blood cells of patients with oral cancer in the course of anticancer chemotherapy. In this study, we will examine the relationship between the expression level of mRNA of apoptosis-related proteins and clinical manifestation of the side effects. Since the know-how that is estabished by feasibility study using peripheral blood cells is applicable to the examination using tumor cells obtained by fine needle aspiration, an evaluation system proposed in this project will yield useful information conceming the effect of anticancer agents.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kentaro Nakayama, Atsuko Kanzaki, Nouri Neamati, Kunihiko Terada, Masato Mutoh, Kenji Ogawa, Shiro Mori, Hitoshi Okamura, Kohji Miyazaki, Toshihiro Sugiyama, Manabu Fukumoto, Yuji Takebayshi: "Expression of Copper-Transporting P-type Adencsine Triphosphat
Kentaro Nakayama、Atsuko Kanzaki、Nouri Neamati、Kunihiko Terada、Masato Mutoh、Kenji Okawa、Shiro Mori、Hitoshi Okamura、Kohji Miyazaki、Toshihiro Sugiyama、Manabu Fukumoto、Yuji Takebayshi:“铜传输 P 型腺苷三磷酸的表达
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
森川秀広, 森士朗, 佐藤敦, 松田耕策, 一迫玲, 他: "上顎歯肉癌患者にみられた頸部リンパ節炎型トキソプラズマ症の1例"日口外誌. 47. 420-423 (2001)
Hidehiro Morikawa、Shiro Mori、Atsushi Sato、Kosaku Matsuda、Rei Ichisako 等:“在上颌牙龈癌患者中观察到的颈部淋巴结炎型弓形虫病病例”Nippon Oral Journal 47. 420-423 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hitoshi Miyashita, Yuji Takebayashi, Yasutaka Nitta, Atsushi Sato, Hidehiro Morikawa, Fumihiro Fujimori, Arita Ohashi, Jatnes F. Fliason, Katutoshi Motegi, Manabu Fukumoto, Shiro Mori, Takafumi Uchida: "Uridine Phcsphctelase is a potential prognostic fact
Hitoshi Miyashita、Yuji Takebayashi、Yasutaka Nitta、Atsushi Sato、Hidehiro Morikawa、Fumihiro Fujimori、Arita Ohashi、Jatnes F. Fliason、Katutoshi Motegi、Manabu Fukumoto、Shiro Mori、Takafumi Uchida:“尿苷 Phcsphctelase 是一个潜在的预后事实
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
佐藤敦, 友寄泰樹, 山崎慎司, 森士朗, 森川秀広, 山口泰: "口腔扁平上皮癌におけるCyclin D1. p16 cyclin dependent kinase 4. RBprotein, Ki67およびα-cateninの発現"東北大歯誌. 20(1). 17-26 (2001)
Atsushi Sato、Yasuki Tomoyori、Shinji Yamazaki、Shiro Mori、Hidehiro Morikawa、Yasushi Yamaguchi:“口腔鳞状细胞癌中细胞周期蛋白 D1.p16 细胞周期蛋白依赖性激酶 4 的表达。RB 蛋白、Ki67 和 α-连环蛋白”《东北大学牙科杂志》20。 (1). 17-26 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
An experimental study for development of real time diagnosis system for oral cancer treatment using nanobubbles and ultrasound
-
批准号:21592550
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:MORIKAWA Hidehiro
-
依托单位:
A feasibility study for the treatment of oral cancer using a new drug delivery system and cell inhibitor
-
批准号:19592334
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:MORIKAWA Hidehiro
-
依托单位:
Experimental study for development of microbubble applicable to clinical use in oral cancer chemotherapy
-
批准号:17592064
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2005
-
负责人:MORIKAWA Hidehiro
-
依托单位:
A possible evaluation system for effect of oral cancer chemotherapy based on the grading of apoptotic changes in the carcinoma cells
-
批准号:11671975
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1999
-
负责人:MORIKAWA Hidehiro
-
依托单位:
海外基金